title: [Value of dolasetron mesilate in treatment of postoperative nausea and vomiting].
authors.forename: R
authors.initials: R
authors.lastname: Badaoui
authors.forename: A
authors.initials: A
authors.lastname: Yagoubi
authors.forename: F
authors.initials: F
authors.lastname: Carpentier
authors.forename: M
authors.initials: M
authors.lastname: Riboulot
authors.forename: M
authors.initials: M
authors.lastname: Ossart
mesh_terms: D000328:Adult; D000932:Antiemetics / Q000009:adverse effects / Q000627:therapeutic use*; D002763:Cholecystectomy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008787:Metoclopramide / Q000009:adverse effects / Q000627:therapeutic use; D020250:Postoperative Nausea and Vomiting / Q000188:drug therapy*; D011807:Quinolizines / Q000009:adverse effects / Q000627:therapeutic use*; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000932:Antiemetics; D007211:Indoles; D011807:Quinolizines; D012702:Serotonin Antagonists; C060344:dolasetron; D008787:Metoclopramide
vernacular_title: Apport du mésilate de dolasétron dans le traitement des nausées et vomissements postopératoires.